Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 14,756	$ 9,291
Prepaid expenses and other current assets	1,415	1,273
Other receivables	759	744
Total current assets	16,930	11,308
Restricted cash	5,390	5,480
Property and equipment, net	12,560	13,241
Operating lease right-of-use asset	39,917	41,687
In-process research and development	10,256	10,256
Goodwill	3,490	3,490
Other assets	973	975
Total assets	89,516	86,437
Current liabilities
Accounts payable and accrued liabilities	1,999	2,055
Accrued compensation	1,843	2,280
Convertible Loan, current	48,088
Term debt, current	82,992	38,954
Current portion of operating lease liabilities	4,525	4,431
Other current liabilities	503	529
Total current liabilities	139,950	48,249
Convertible Loan, non-current		32,897
Term debt, non-current	15,240	22,539
Operating lease liabilities, net of current portion	26,837	27,694
Deferred tax liability	3,077	3,077
Total liabilities	185,104	134,456
Commitments and contingencies (Note 12)
Stockholders' deficit
Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,193,479 and 36,229,842 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	362	362
Additional paid-in capital	281,286	279,354
Accumulated deficit	(377,236)	(327,735)
Total stockholders' deficit	(95,588)	(48,019)
Total liabilities and stockholders' deficit	$ 89,516	$ 86,437